ViiV Healthcare Licensing: Expanding Access to ...

By HEOR Staff Writer

July 30, 2025

ViiV Healthcare has expanded its voluntary licensing agreement with the Medicines Patent Pool. The update now includes access to long-acting injectable cabotegravir (CAB LA) for HIV treatment. This allows generic manufacturers to supply the therap...
Transforming Brain Health Innovation with Patient Experience Data: Strategic ...
Comprehensive Review of Type 2 Diabetes Treatment and Diagnosis Strategies
DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expan...
Efficacy and Insights of Transdiagnostic Mental Health Apps for Depression an...
Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical ...
Telemedicine Growth Strategies: Insights from the WHO European Region
The Case for Transparency in Peer Review: Enhancing Scientific Integrity and ...
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
EU Establishes Expert Panel for Orphan Paediatric Devices
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
Revolutionizing Hepatitis C Treatment: The Transformative Role of Direct-Acti...
Empowering Health: The Role of Self-Care and NCDs in Global Health Policy